Hematologist
CION Cancer Clinics
Salvage chemotherapy and autologous transplant for relapsed DLBCL | CION Cancer Clinics
If DLBCL comes back later rather than early, salvage chemotherapy followed by high-dose chemotherapy and a transplant of your own stem cells remains a standard option for people fit enough. It only goes ahead if the lymphoma responds to salvage first. If it returned within a year or never responded, CAR-T is often discussed instead. This page walks through each step, who it suits and what to ask. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What are salvage chemotherapy and an autologous transplant?
- What happens, step by step?
- Who is this route suited to, and who is it not?
- What do the words in the treatment plan mean?
- What do families often believe about transplant that is not true?
- What should you ask, and what can this page not tell you?
- Common questions about salvage chemotherapy and transplant
The short answer
What are salvage chemotherapy and an autologous transplant?
If DLBCL comes back or does not fully respond to first treatment, salvage chemotherapy is the next course of different drugs given to shrink it again. If it responds well, high-dose chemotherapy followed by a transplant of your own stem cells, called an autologous transplant, may be offered to deepen and hold that response.
Why "salvage" does not mean hopeless
The word sounds frightening, but in lymphoma it simply means second-line treatment. It is a planned, well-studied route, and some people treated this way stay in long-term remission, which means no sign of lymphoma on tests.
Why your own stem cells are needed
The high-dose chemotherapy used before a transplant is strong enough to wipe out the bone marrow, the factory inside the bones that makes blood. Stem cells collected from your own blood earlier are given back through a drip. They travel to the marrow and start making blood cells again.
Where CAR-T fits in now
Timing matters. If the lymphoma came back within a year of finishing first treatment, or never responded, guidelines now often favour CAR-T cell therapy over this route. If it came back later, salvage chemotherapy and transplant remain a standard option. Your team weighs both with you.
The pathway
What happens, step by step?
The whole journey usually takes a few months. Each stage depends on the one before going well.
-
A new biopsy and scans
Most teams want a fresh biopsy to confirm the lymphoma has returned and has not changed type, plus a PET-CT to map where it is.
-
Salvage chemotherapy
A few cycles of a combination such as R-ICE, R-DHAP or R-GDP. These are often given with a short hospital stay for each cycle.
-
A scan to check the response
A PET-CT after salvage shows whether the lymphoma is responding well enough for a transplant to be worth it.
-
Collecting your stem cells
Injections move stem cells from the marrow into the blood. A machine then collects them through a drip over one or more sessions, and they are frozen until needed.
-
High-dose chemotherapy and stem cell return
You stay in a specialist transplant unit. After high-dose treatment, the frozen cells are thawed and given back through a drip.
-
Recovery of the blood counts
For a period your counts are very low and infection risk is high. You stay in hospital until the new cells start working, then recover at home over the following months.
Not sure whether this applies to you?
Ask an oncologistWeighing it up
Who is this route suited to, and who is it not?
Often suited to
People whose lymphoma came back some time after first treatment, and who are fit enough for intensive treatment.
The team looks for
- A good response to salvage chemotherapy
- Heart, lungs and kidneys working well
- Being active day to day
Often not suited to
People who are frail, have serious heart, lung or kidney illness, or whose lymphoma did not respond to salvage chemotherapy. For them the risks of high-dose treatment outweigh the likely benefit.
Early relapse or no response
When the lymphoma returns soon after first treatment or never responds, CAR-T or other newer options are often discussed first. Transplant may still be considered in some situations.
Age alone is not the deciding factor
An older person who is fit may be offered a transplant. A younger person with other serious illness may not. Fitness and the lymphoma's behaviour matter more than the date of birth.
!
One thing that cannot wait
During salvage chemotherapy and after a transplant, a fever, shivering, or suddenly feeling very unwell can be the first sign of a serious infection. Contact the treating team at once or go to the nearest emergency department, or call 108. Say that the person is on lymphoma treatment. Do not wait until morning to see whether it settles on its own.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your plan
What do the words in the treatment plan mean?
- Relapsed
- The lymphoma responded to first treatment and then came back.
- Refractory
- The lymphoma did not respond, or did not respond enough, to treatment.
- R-ICE, R-DHAP, R-GDP
- Short names for salvage combinations. Each letter stands for one drug; the R is rituximab.
- Stem cell harvest (apheresis)
- Collecting stem cells from your blood through a machine, a little like a long blood donation.
- Conditioning (for example BEAM)
- The high-dose chemotherapy given just before the stem cells go back in.
- Engraftment
- The point at which the returned stem cells start making new blood cells.
Commonly believed
What do families often believe about transplant that is not true?
"We need to find a matching donor in the family."
Not for an autologous transplant. The stem cells are your own, collected before the high-dose treatment. A donor is needed only for an allogeneic transplant, which is a different treatment used in other situations.
"A transplant is an operation."
There is no surgery. The stem cells go in through a drip, like a blood transfusion. The hard part is the high-dose chemotherapy before it and the weeks of very low counts after it.
"If the lymphoma came back, nothing else can work."
Relapsed DLBCL is treated with intent to control it for the long term. Salvage chemotherapy, transplant, CAR-T and bispecific antibodies are all options, and the right order depends on timing and fitness.
"Going straight to transplant saves time."
The transplant only helps if the lymphoma responds to salvage chemotherapy first. Skipping that step removes the test that tells the team whether the transplant is worth its risks.
Being straight with you
What should you ask, and what can this page not tell you?
This page cannot tell you whether a transplant is right for you, or what your outlook would be. That depends on when the lymphoma came back, how it responds to salvage treatment, your fitness and the lymphoma's features on biopsy.
Questions worth asking the team
Ask whether your relapse counts as early or late, and whether CAR-T should be considered instead. Ask how the response to salvage will be judged, where the stem cell collection and transplant would take place, how long the hospital stay is likely to be, and who in the family will need to stay nearby during recovery.
How CION helps
Transplants are carried out in specialist transplant units. CION's haematology team reviews your biopsy, scans and treatment history, presents your case at a tumour board, and coordinates referral and care with qualified transplant centres. You are not left to find the route on your own.
Scheme rules for transplant cover change often. Check current Aarogyasri, PM-JAY, CGHS, ECHS, EHS or insurance terms before admission.Questions we are asked
Common questions about salvage chemotherapy and transplant
How long will my father be in hospital for the transplant?
The main stay is usually a few weeks, from the high-dose chemotherapy until his blood counts recover enough to be safe at home. Salvage cycles and stem cell collection before that may need shorter stays. The transplant centre will give a clearer estimate once the plan is fixed.
Does salvage chemotherapy have more side effects than R-CHOP?
It is often more intensive. Low blood counts, infections, tiredness, feeling sick and effects on the kidneys or hearing can occur, depending on the drugs used. The team checks blood tests closely and adjusts supportive care. Report any new symptom early rather than waiting for the next visit.
What if the lymphoma does not respond to salvage chemotherapy?
Then a transplant is usually not advised, because it is unlikely to help. Other options such as CAR-T, bispecific antibodies, clinical trials or treatment focused on comfort and control of symptoms may be discussed. Ask the team to explain each option and what it asks of the patient.
How are stem cells collected? Does it hurt?
Injections first push stem cells out into the blood, which can cause bone aches. Collection is done through a drip connected to a machine while you sit or lie down for some hours. Most people find it tiring rather than painful. Sometimes a second session is needed.
Will hair loss and low counts happen again?
Usually, yes. High-dose chemotherapy causes hair loss and a period of very low counts, which is why the stay is in a protected unit. Hair normally grows back in the months afterwards. Blood and platelet transfusions are often needed until the new cells take over.
What precautions are needed at home afterwards?
The immune system takes months to recover. The team will advise on food hygiene, avoiding crowds and sick visitors, and when to restart work or travel. Childhood vaccines often need to be given again later. Follow the written plan from the transplant centre closely.
Is transplant covered by Aarogyasri or insurance?
Autologous transplant for lymphoma is covered under some government schemes and many insurance policies, but package limits and approved centres vary. Rules change, so ask the transplant centre's insurance desk to check your current Aarogyasri, PM-JAY, CGHS, ECHS, EHS or policy cover in writing.
Can CION review whether transplant or CAR-T suits us better?
Yes. Bring the first biopsy, the new biopsy, all PET reports and a summary of first treatment with dates. CION's haematology team reviews these, discusses the case at a tumour board, explains the choices and coordinates with qualified centres for the route you choose.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NICE — Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and high-grade B-cell lymphoma that relapses within 12 months after first-line chemoimmunotherapy (TA895)
- American Cancer Society — High-Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin Lymphoma
- National Cancer Institute — Adult Non-Hodgkin Lymphoma Treatment (PDQ) - Patient Version
- Leukemia & Lymphoma Society — Non-Hodgkin Lymphoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Lymphoma back after first treatment?
Share the biopsy and scan reports. CION's haematology team will review them, discuss the case at a tumour board and explain the options. One helpline serves every CION centre.